Mild-to-moderate active luminal Crohn's disease

Détails

ID Serval
serval:BIB_4915B5DB3778
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Mild-to-moderate active luminal Crohn's disease
Périodique
Digestion
Auteur(s)
Michetti  Pierre, Juillerat  Pascal, Mottet  Christian, Pittet  Valérie, Gonvers  Jean-Jacques, Vader  John-Paul, Froehlich  Florian, Felley  Christian
ISSN
0012-2823
Statut éditorial
Publié
Date de publication
2007
Peer-reviewed
Oui
Volume
76
Numéro
2
Pages
92-98
Langue
anglais
Notes
SAPHIRID:64242
Résumé
The management of luminal Crohn's disease, the most common form of initial presentation of the disease, depends on the location and the severity of the disease. Mild-to-moderate disease represents a relatively large proportion of patients with a first flare of luminal disease, which may also be associated with perianal disease. As quality of life of these patients inversely correlates with disease activity, adequate therapy is a central goal of the overall patient management. Treatment options include mainly sulfasalazine, budesonide and systemic steroids, while the role of mesalazine and antibiotics remains controversial. The role of biological therapies has not been thoroughly evaluated in patients with mild disease. [Ed.]
Pubmed
Web of science
Création de la notice
03/03/2008 11:52
Dernière modification de la notice
20/08/2019 14:56
Données d'usage